Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen Diwan
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Anshen Diwan is a Traditional Chinese Medicine (TCM) product developed by Tianjin Tasly Pharmaceutical Co., Ltd., primarily indicated for the treatment of insomnia and related symptoms such as anxiety, restlessness, and dizziness. It is formulated as "dripping pills" (diwan), a modern TCM dosage form designed to enhance the solubility and bioavailability of herbal extracts. The preparation typically contains a combination of herbs including *Semen Ziziphi Spinosae* (Suanzaoren), *Radix Polygalae* (Yuanzhi), *Poria cocos* (Fuling), and *Gardenia jasminoides* (Zhizi). These components are traditionally used to nourish the heart, soothe the liver, and calm the nerves. Pharmacologically, Anshen Diwan is thought to exert its sedative and hypnotic effects by modulating the central nervous system, particularly through the enhancement of GABAergic signaling and the regulation of neurotransmitters such as serotonin and dopamine. It is widely utilized in China as a regulated pharmaceutical for sleep disorders.
- Brand names
- Anshen Diwan
- Other names
- Anshen Dripping PillsTasly Anshen Diwan
02
Targets
GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)5-HT (Serotonin receptors)DRD (Dopamine receptors)
Beyond the preview
Go deeper on Anshen Diwan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anshen Diwan.